Frank Niehaus

Title: Frank Niehaus: Innovator in Biotechnology

Introduction

Frank Niehaus is a notable inventor based in Heppenheim, Germany. He has made significant contributions to the field of biotechnology, holding a total of seven patents. His work primarily focuses on advancements in wound care and expression systems.

Latest Patents

One of his latest patents is related to a protease for wound conditioning and skin care. This invention involves a protease derived from the larvae of Lucilia sericata, known as debrilase, which is effective for debridement of wounds. The patent describes a nucleic acid molecule encoding a serine protease capable of cleaving fibrin and casein. It includes various specifications regarding the amino acid and nucleotide sequences, emphasizing the importance of identity percentages for effective functionality. Another significant patent involves an archaeon expression system, which includes a sulfolobus expression vector designed for gene expression and selection in host cells. This invention also encompasses a shuttle vector and methods for generating infectious subviral particles.

Career Highlights

Throughout his career, Frank Niehaus has worked with prominent companies in the biotechnology sector, including B.R.A.I.N. Biotechnology Research and Information Network AG and Henkel AG & Company, KGaA. His experience in these organizations has contributed to his innovative work and patent developments.

Collaborations

Frank has collaborated with notable colleagues such as Jürgen Eck and Susanne Wieland. Their combined expertise has likely enhanced the quality and impact of their research and inventions.

Conclusion

Frank Niehaus is a distinguished inventor whose work in biotechnology has led to significant advancements in wound care and expression systems. His contributions are recognized through multiple patents that reflect his innovative spirit and dedication to improving healthcare solutions.